清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Real-World Effectiveness of Biologic Therapy in Allergic Bronchopulmonary Aspergillosis

医学 过敏性支气管肺曲菌病 曲菌病 重症监护医学 免疫学 免疫球蛋白E 抗体
作者
Charlotte Carter,Irene Berrar Torre,Sophia Blackburn,Lisa Nwankwo,Tom Semple,Bhavin Rawal,Darius Armstrong‐James,Pujan H. Patel,Anand Shah
出处
期刊:The Journal of Allergy and Clinical Immunology: In Practice [Elsevier BV]
卷期号:13 (5): 1094-1102.e1 被引量:9
标识
DOI:10.1016/j.jaip.2025.03.006
摘要

BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is characterized by a severe hypersensitivity reaction to Aspergillus species. Current treatment relies on oral corticosteroids (OCS) and triazole antifungal therapy, but there is increasing evidence of the benefits of biologic therapies targeting type 2 inflammatory pathways. OBJECTIVE: To assess the real-world effectiveness of biologic therapies in patients with ABPA. METHODS: We performed a large retrospective single-center analysis of patients with ABPA as defined by the modified International Society for Human and Animal Mycology (ISHAM) criteria between 2014 and 2022. Baseline characteristics were recorded. Clinical outcomes were assessed at 12 months after commencement of a biologic including symptom scores, exacerbation frequency, corticosteroid use, and multidisciplinary team consensus of effectiveness. RESULTS: A total of 74 patients received a biologic, of whom 32% (n = 24) received anti-IgE therapy, 65% (n = 48) anti-IL5/5Rα therapy, and 3% (n = 2) anti-IL4-Rα therapy. Of the total, 65% (n = 48) patients were deemed to have a successful response at 12 months with a ≥50% reduction in OCS use and 35% (n = 26) stopped or changed biologic during the follow-up period because of failed clinical response (n = 21), side effects (n = 4), or medical comorbidities (n = 1). There was a significant reduction in the 6-item Asthma Control Questionnaire score (P < .0001), exacerbation rate over 12 months (P < .0001), and maintenance OCS use (P = .0173). Univariate analysis revealed that mucus plugging was associated with nonresponse to biologic therapy (P = .0189). CONCLUSION: Biologic therapies are effective in a number of patients with ABPA. However, further prospective clinical trials are required to determine the effectiveness and which phenotypes likely to respond. These data nevertheless increase the evidence base for biologics in ABPA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
落桐完成签到,获得积分10
4秒前
zhangfengyu玉完成签到 ,获得积分10
4秒前
5秒前
10秒前
拂晓完成签到,获得积分10
12秒前
火星豹完成签到 ,获得积分10
12秒前
15秒前
20秒前
红雨灰衣完成签到 ,获得积分10
22秒前
22秒前
24秒前
旧雨新知完成签到 ,获得积分10
26秒前
如我所愿完成签到 ,获得积分10
26秒前
秀丽雨柏完成签到,获得积分10
28秒前
29秒前
ubless607的应助被科研通管家采纳,获得10
30秒前
wq完成签到 ,获得积分10
32秒前
千陽完成签到 ,获得积分10
33秒前
flysky120完成签到 ,获得积分10
34秒前
34秒前
38秒前
小幺完成签到 ,获得积分10
43秒前
43秒前
hyw完成签到,获得积分10
44秒前
47秒前
48秒前
liao完成签到 ,获得积分10
49秒前
52秒前
风趣的月光完成签到 ,获得积分10
54秒前
57秒前
还行啊完成签到,获得积分10
1分钟前
1分钟前
hui完成签到 ,获得积分10
1分钟前
愉快初曼完成签到,获得积分10
1分钟前
高大的凡阳完成签到 ,获得积分10
1分钟前
梨落南山雪完成签到 ,获得积分10
1分钟前
1分钟前
超多肉肉肉肉完成签到 ,获得积分10
1分钟前
谦让大米完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185496
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834498
捐赠科研通 7783092
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558949
邀请新用户注册赠送积分活动 2481346